The influence of folate and methionine on intestinal tumour development in the Apc Min/+ mouse model

Mutation Research - Reviews in Mutation Research

Volumn 751, Issue 1, 2012, Pages 64-75

  Teh, Arnida Hani ^a,b,c   Symonds, Erin ^d   Bull, Caroline ^a,b   Clifton, Peter ^e   Fenech, Michael ^a  

^a CSIRO   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^d ROYAL ADELAIDE HOSPITAL   (Australia)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Folate; Intestinal cancer; Methionine, Apc Min +

Indexed keywords

APC PROTEIN; FOLIC ACID; METHIONINE;

AMINO ACID DEFICIENCY; CANCER GROWTH; CANCER RISK; CELL DIVISION; CHROMOSOMAL INSTABILITY; COLON CANCER; COLORECTAL CANCER; DIET RESTRICTION; DNA METHYLATION; FOLIC ACID DEFICIENCY; GENE MUTATION; GENOTYPE; HUMAN; METHIONINE DEFICIENCY; NONHUMAN; NUCLEOTIDE METABOLISM; POLYAMINE METABOLISM; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE TUMOR;

EID: 84862228290     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2012.05.001     Document Type: Review

References (105)

1. Vishnumohan S., Arcot J., Sini S., Uthira L., Ramachandran S. Determination of folate contents in selected Indian foods using the tri-enzyme extraction and estimated folate intakes of the population based on 24-h recall. Int. J. Food Sci. Nutr. 2009, 60:170-180.
2. Allen L.H. Causes of vitamin B12 and folate deficiency, food &# 38. Nutr. Bull. 2008, 29:20-34.
3. Nutrient Reference Values for Australia and New Zealand, in: NHMRC (Ed.), 2006.
4. Kim Y.I. Will mandatory folic acid fortification prevent or promote cancer?. Am. J. Clin. Nutr. 2004, 80:1123-1128.
5. Boushey C., Beresford S., Omenn G., Motulsky A. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995, 274:1049-1057.
6. Giovannucci E., Stampfer M.J., Colditz G.A., Hunter D.J., Fuchs C., Rosner B.A., Speizer F.E., Willett W.C. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann. Intern. Med. 1998, 129:517-524.
7. Glynn S.A., Albanes D. Folate and cancer: a review of the literature. Nutr. Cancer 1994, 22:101-119.
8. Fenech M. The role of folic acid and vitamin B12 in genomic stability of human cells. Mutat. Res. 2001, 475:57-67.
9. James S.J., Pogribny I.P., Pogribna M., Miller B.J., Jernigan S., Melnyk S. Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis. J. Nutr. 2003, 133:3740S-3747S.
10. Martinov M., Vitvitsky V., Banerjee R., Ataullakhanov F. The logic of the hepatic methionine metabolic cycle. Biochim.Biophys. Acta 2010, 1804:89-96.
11. Schrauzer G.N. Selenomethionine: a review of its nutritional significance, metabolism and toxicity. J. Nutr. 2000, 130:1653-1656.
12. Altenbach S.B., Pearson K.W., Leung F.W., Sun S.S.M. Cloning and sequence analysis of a cDNA encoding a Brazil nut protein exceptionally rich in methionine. Plant Mol. Biol. 1987, 8:239-250.
13. Oomah B.D. Flaxseed as a functional food source. J. Sci. Food Agric. 2001, 81:889-894.
14. Zhang S., Hunter D.J., Hankinson S.E., Giovannucci E.L., Rosner B.A., Colditz G.A., Speizer F.E., Willett W.C. A prospective study of folate intake and the risk of breast cancer. JAMA 1999, 281:1632-1637.
15. Kalhan S., Edmison J., Marczewski S., Dasarathy S., Gruca L., Bennett C., Duenas C., Lopez R. Methionine and protein metabolism in non-alcoholic steatohepatitis: evidence for lower rate of transmethylation of methionine. Clin. Sci. 2011, 121:179-189.
16. Pegg A.E. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 1988, 48:759-774.
17. Wallace H.M., Fraser A.V., Hughes A. A perspective of polyamine metabolism. Biochem. J. 2003, 376:1-14.
18. Ghoshal A., Farber E. The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens. Carcinogenesis 1984, 5:1367-1370.
19. Bataille F., Rogler G., Modes K., Poser I., Schuierer M., Dietmaier W., Ruemmele P., Mühlbauer M., Wallner S., Hellerbrand C. Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-catenin. Lab. Invest. 2004, 85:124-136.
20. Jones P.A., Takai D. The role of DNA methylation in mammalian epigenetics. Science 2001, 293:1068-1070.
21. Grundy F.J., Henkin T.M. Synthesis of Serine, Glycine, Cysteine 2002, Amer Society for Microbiology.
22. Carmona F.J., Esteller M. Epigenomics of human colon cancer. Mutat. Res. 2010, 693:53-60.
23. Kim M.S., Lee J., Sidransky D. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev. 2010, 29:181-206.
24. Sharma S., Kelly T.K., Jones P.A. Epigenetics in cancer. Carcinogenesis 2010, 31:27-36.
25. Reddy L., Odhav B., Bhoola K. Natural products for cancer prevention: a global perspective. Pharmacol. Ther. 2003, 99:1-13.
26. Abdulla M., Gruber P. Role of diet modification in cancer prevention. Biofactors 2000, 12:45-52.
27. Farber E. The multistep nature of cancer development. Cancer Res. 1984, 44:4217-4223.
28. Clapp R.W., Jacobs M.M., Loechler E.L. Environmental and occupational causes of cancer new evidence, 2005-2007. Rev. Environ. Health 2008, 23:1-37.
29. Doll R., Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 1981, 66:1191-1308.
30. Boffetta P. Human cancer from environmental pollutants: the epidemiological evidence. Mutat. Res. 2006, 608:157-162.
31. Kim Y. Role of folate in colon cancer development and progression. J. Nutr. 2003, 133:3731S-3739S.
32. Duthie S.J. Folic acid deficiency and cancer: mechanisms of DNA instability. Br. Med. Bull. 1999, 55:578-592.
33. Ulrich C. Nutrigenetics in cancer research-folate metabolism and colorectal cancer. J. Nutr. 2005, 135:2698-2702.
34. Ulrich C.M., Potter J.D. Folate supplementation: too much of a good thing?. Cancer Epidemiol. Biomarkers Prev. 2006, 15:189-193.
35. Kim Y.I. Folate and carcinogenesis: evidence, mechanisms, and implications. J. Nutr. Biochem. 1999, 10:66-88.
36. Giovannucci E., Rimm E.B., Ascherio A., Stampfer M.J., Colditz G.A., Willett W.C. Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J. Natl. Cancer Inst. 1995, 87:265-273.
37. Komninou D., Leutzinger Y., Reddy B.S., Richie J.P. Methionine restriction inhibits colon carcinogenesis. Nutr. Cancer 2006, 54:202-208.
38. Smith A.D., Kim Y.I., Refsum H. Is folic acid good for everyone?. Am. J. Clin. Nutr. 2008, 87:517-533.
39. Paulsen J.E., Alexander J. Growth stimulation of intestinal tumours in Apc(Min/+) mice by dietary l-methionine supplementation. Anticancer Res. 2001, 21:3281-3284.
40. Luongo C., Moser A., Gledhill S., Dove W. Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res. 1994, 54:5947.
41. Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., Joslyn G., Stevens J., Spirio L., Robertson M. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991, 66:589-600.
42. Sieber O.M., Segditsas S., Knudsen A.L., Zhang J., Luz J., Rowan A.J., Spain S.L., Thirlwell C., Howarth K.M., Jaeger E. Disease severity and genetic pathways in attenuated familial adenomatous polyposis vary greatly but depend on the site of the germline mutation. Gut 2006, 55:1440-1448.
43. Jasperson K., Tuohy T., Neklason D., Burt R. Hereditary and familial colon cancer. Gastroenterology 2010, 138:2044-2058.
44. Polakis P. Wnt signaling and cancer. Genes Dev. 2000, 14:1837-1851.
45. Fodde R., Smits R., Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer 2001, 1:55-67.
46. Banerjee A., Quirke P. Experimental models of colorectal cancer. Dis. Colon Rectum 1998, 41:490-505.
47. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996, 87:159-170.
48. Su L.K., Kinzler K.W., Vogelstein B., Preisinger A.C., Moser A.R., Luongo C., Gould K.A., Dove W.F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992, 256:668-670.
49. Moser A.R., Pitot H.C., Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990, 247:322-324.
50. Wallace M., Phillips R. Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br. J. Surg. 1998, 85:742-750.
51. Moser A., Luongo C., Gould K., McNeley M., Shoemaker A., Dove W. ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur. J. Cancer 1995, 31:1061-1064.
52. Fodde R. The multiple functions of tumour suppressors: it's all in APC. Nat. Cell Biol. 2003, 5:190-192.
53. Näthke I. The adenomatous polyposis coli protein: the Achilles heel of the gut epithelium. Annu. Rev. Cell Dev. Biol. 2004, 20:337-366.
54. Nusse R. Wnt signaling in disease and in development. Cell Res. 2005, 15:28-32.
55. Cong F., Schweizer L., Chamorro M., Varmus H. Requirement for a nuclear function of {beta}-catenin in Wnt signaling. Mol. Cell. Biol. 2003, 23:8462-8470.
56. Myant K., Sansom O.J. Wnt/Myc interactions in intestinal cancer: partners in crime. Exp. Cell Res. 2011, 317:2725-2731.
57. Song J., Medline A., Mason J.B., Gallinger S., Kim Y.I. Effects of dietary folate on intestinal tumorigenesis in the Apc(Min) mouse. Cancer Res. 2000, 60:5434-5440.
58. Song J., Sohn K.J., Medline A., Ash C., Gallinger S., Kim Y.I. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice. Cancer Res. 2000, 60:3191-3199.
59. Tucker J.M., Davis C., Kitchens M.E., Bunni M.A., Priest D.G., Spencer H.T., Berger F.G. Response to 5-fluorouracil chemotherapy is modified by dietary folic acid deficiency in Apc(Min/+) mice. Cancer Lett. 2002, 187:153-162.
60. Sibani S., Melnyk S., Pogribny I.P., Wang W., Hiou-Tim F., Deng L., Trasler J., Jill James S., Rozen R. Studies of methionine cycle intermediates (SAM, SAH), DNA methylation and the impact of folate deficiency on tumor numbers in Min mice. Carcinogenesis 2002, 23:61-65.
61. Trasler J., Deng L., Melnyk S., Pogribny I., Hiou-Tim F., Sibani S., Oakes C., Li E., James S.J., Rozen R. Impact of Dnmt1 deficiency, with and without low folate diets, on tumor numbers and DNA methylation in Min mice. Carcinogenesis 2003, 24:39-45.
62. Bashir O., FitzGerald A., Goodlad R. Both suboptimal and elevated vitamin intake increase intestinal neoplasia and alter crypt fission in the ApcMin/+ mouse. Carcinogenesis 2004, 25:1507-1515.
63. Lawrance A.K., Deng L., Brody L.C., Finnell R.H., Shane B., Rozen R. Genetic and nutritional deficiencies in folate metabolism influence tumorigenicity in Apcmin/+ mice. J. Nutr. Biochem. 2007, 18:305-312.
64. McKay J.A., Williams E.A., Mathers J.C. Sex-specific modulation of tumorigenesis by folic acid supply in the Apc mouse during early neonatal life. Br. J. Nutr. 2008, 99:550-558.
65. Lawrance A.K., Deng L., Rozen R. Methylenetetrahydrofolate reductase deficiency and low dietary folate reduce tumorigenesis in Apc min/+ mice. Gut 2009, 58:805-811.
66. MacFarlane A.J., Perry C.A., McEntee M.F., Lin D.M., Stover P.J. Mthfd1 is a modifier of chemically induced intestinal carcinogenesis. Carcinogenesis 2011, 32:427-433.
67. MacFarlane A.J., Perry C.A., McEntee M.F., Lin D.M., Stover P.J. Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of apcmin-mediated intestinal cancer risk. Cancer Res. 2011, 71:2098-2107.
68. Mckay J.A., Williams E.A., Mathers J.C. Frontiers: effect of maternal and post-weaning folate supply on gene-specific dna methylation in the small intestine of weaning and adult Apc+/Min and wild type mice. Front. Epigenomics 2011, 2:1-8.
69. Reeves P.G. Components of the AIN-93 diets as improvements in the AIN-76A diet. J. Nutr. 1997, 127:838S.
70. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123(11):1939-1951.
71. Song J., Rechkoblit O., Bestor T.H., Patel D.J. Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation. Science 2011, 331:1036-1040.
72. Vasen H., Stormorken A., Menko F., Nagengast F., Kleibeuker J., Griffioen G., Taal B., Moller P., Wijnen J. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J. Clin. Oncol. 2001, 19:4074-4080.
73. Stover P.J. One-carbon metabolism-genome interactions in folate-associated pathologies. J. Nutr. 2009, 139:2402-2405.
74. James S., Cross D., Miller B. Alterations in nucleotide pools in rats fed diets deficient in choline, methionine and/or folic acid. Carcinogenesis 1992, 13:2471-2474.
75. James S., Basnakian A., Miller B. In vitro folate deficiency induces deoxynucleotide pool imbalance, apoptosis, and mutagenesis in Chinese hamster ovary cells. Cancer Res. 1994, 54:5075-5080.
76. Choi S., Kim Y., Weitzel J., Mason J. Folate depletion impairs DNA excision repair in the colon of the rat. Gut 1998, 43:93-99.
77. Ames B. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer 1. Mutat. Res. 2001, 475:7-20.
78. Sancar A., Lindsey-Boltz L.A., ünsal-Kaçmaz K., Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 2004, 73:39-85.
79. Kamen B. Folate and antifolate pharmacology. Semin. Oncol. 1997, 24(5 Suppl. 18). S18-30-S18-39.
80. Song J., Sohn K.J., Medline A., Ash C., Gallinger S., Kim Y.I. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/- Msh2-/- Mice. Cancer Res. 2000, 60:3191-3199.
81. Ma D.W., Finnell R.H., Davidson L.A., Callaway E.S., Spiegelstein O., Piedrahita J.A., Salbaum J.M., Kappen C., Weeks B.R., James J., Bozinov D., Lupton J.R., Chapkin R.S. Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis. Cancer Res. 2005, 65:887-897.
82. Mackey A., Picciano M. Maternal folate status during extended lactation and the effect of supplemental folic acid. Am. J. Clin. Nutr. 1999, 69:285-292.
83. Wainfan E., Poirier L.A. Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res. 1992, 52:2071S-2077S.
84. Laird P., Jaenisch R. The role of DNA methylation in cancer genetics and epigenetics. Annu. Rev. Genet. 1996, 30:441-464.
85. Holliday R. The inheritance of epigenetic defects. Science 1987, 238:163-170.
86. Tycko B. Epigenetic gene silencing in cancer. J. Clin. Invest. 2000, 105:401-407.
87. Costello J.F., Plass C. Methylation matters. J. Med. Genet. 2001, 38:285-303.
88. Feinberg A., Gehrke C., Kuo K., Ehrlich M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 1988, 48:1159-1161.
89. Makos M., Nelkin B., Lerman M., Latif F., Zbar B., Baylin S. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:1929-1933.
90. Pogribny I.P., Basnakian A.G., Miller B.J., Lopatina N.G., Poirier L.A., James S.J. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Res. 1995, 55:1894-1901.
91. Christman J., Sheikhnejad G., Dizik M., Abileah S., Wainfan E. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis 1993, 14:551-557.
92. Kim Y.I., Pogribny I.P., Basnakian A.G., Miller J.W., Selhub J., James S.J., Mason J.B. Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am. J. Clin. Nutr. 1997, 65:46-52.
93. Jacob R.A., Gretz D.M., Taylor P.C., James S.J., Pogribny I.P., Miller B.J., Henning S.M., Swendseid M.E. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J. Nutr. 1998, 128:1204-1212.
94. Baylln S., Herman J., Graff J., Vertino P., Issa J. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 1997, 72:141-182.
95. Goelz S.E., Vogelstein B. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 1985, 228:187-190.
96. Jones P., Baylin S. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 2002, 3:415-428.
97. Paulsen J.E., Reistad R., Eliassen K.A., Sjaastad Ø.V., Alexander J. Dietary polyamines promote the growth of azoxymethane-induced aberrant crypt foci in rat colon. Carcinogenesis 1997, 18:1871-1875.
98. Gerner E. Impact of dietary amino acids and polyamines on intestinal carcinogenesis and chemoprevention in mouse models. Biochem. Soc. Trans. 2007, 35:322-325.
99. Tucker J., Murphy J., Kisiel N., Diegelman P., Barbour K., Davis C., Medda M., Alhonen L., Jänne J., Kramer D. Potent modulation of intestinal tumorigenesis in Apcmin/+ mice by the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase. Cancer Res. 2005, 65:5390-5398.
100. Newmark H.L., Yang K., Lipkin M., Kopelovich L., Liu Y., Fan K., Shinozaki H. A western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis 2001, 22:1871-1875.
101. Yang K., Kurihara N., Fan K., Newmark H., Rigas B., Bancroft L., Corner G., Livote E., Lesser M., Edelmann W., Velcich A., Lipkin M., Augenlicht L. Dietary induction of colonic tumors in a mouse model of sporadic colon cancer. Cancer Res. 2008, 68:7803-7810.
102. Newmark H.L., Yang K., Kurihara N., Fan K., Augenlicht L.H., Lipkin M. Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis 2009, 30:88-92.
103. Batova A., Diccianni M., Nobori T., Vu T., Yu J., Bridgeman L., Yu A. Frequent deletion in the methylthioadenosine phosphorylase gene in T-cell acute lymphoblastic leukemia: strategies for enzyme-targeted therapy. Blood 1996, 88:3083-3090.
104. Piyathilake C.J., Macaluso M., Celedonio J.E., Badiga S., Bell W.C., Grizzle W.E. Mandatory fortification with folic acid in the United States appears to have adverse effects on histone methylation in women with pre-cancer but not in women free of pre-cancer. Int. J. Women Health 2010, 1:131-137.
105. Tryndyak V.P., Ross S.A., Beland F.A., Pogribny I.P. Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. Mol. Carcinog. 2009, 48:479-487.